Quantcast

Latest Angiogenesis Stories

2015-01-27 08:32:43

New Insights, Discoveries and Interim Clinical Data on Generx® Phase 3 Angiogenic Therapy for Patients with Cardiac Microvascular Insufficiency and Coronary Artery Disease SAN DIEGO,

2015-01-14 20:21:30

-- DIG-KT is a novel bi-specific mAb targeting VEGFR2 and Tie-2 pathways for treating cancers SHENYANG, China and DAEJEON, South Korea, Jan. 14, 2015 /PRNewswire/ -- 3SBio Inc.

2014-12-23 20:21:07

RnRMarketResearch.com adds "Avastin and Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023" to its store.

2014-11-20 08:33:55

Announces Formation of Angionetics and Activation Therapeutics: New Operating Units to Facilitate the Independent Monetization and Funding of Generx® and Excellagen® SAN DIEGO, Nov.

2014-11-18 20:23:20

-- Tanibirumab is a novel VEGFR2-neutralizing mAb for treating cancers SHENYANG, China and DAEJEON, Korea, Nov.

2014-10-29 08:33:08

Data Supportive of GEN-2, an RNAi Carrier for Therapeutic Treatment of Lung Cancer LAWRENCEVILLE, N.J., Oct.

2014-09-18 08:26:01

-- Phase III RAINBOW Trial Data Published in The Lancet Oncology -- INDIANAPOLIS, Sept.

2014-09-12 08:25:08

-- Ramucirumab Plus FOLFIRI Improved Survival in Metastatic Colorectal Cancer following Progression on a Bevacizumab-Based Regimen -- INDIANAPOLIS, Sept.


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related